Literature DB >> 8907279

Non-Hodgkin's lymphoma and hepatitis C virus infection.

A M Brind1, J P Watson, A Burt, P Kestevan, J Wallis, S J Proctor, M F Bassendine.   

Abstract

The hepatitis C virus (HCV) is a recently described and important cause of acute and chronic liver disease. A hallmark of HCV is its propensity to become chronic, some patients with chronic HCV progressing to cirrhosis and hepatocellular carcinoma (HCC). HCV is also lymphotrophic and we report 2 patients with HCV cirrhosis who developed non-Hodgkins lymphoma (NHL). These cases raise the possibility that chronic HCV infection of lymphocytes plays an aetiological role in this malignancy. However screening of a further 63 consecutive patients over the age of 50 years with NHL for HCV antibody by second generation enzyme linked immunoassay (ELISA) failed to identify any patients with evidence of HCV infection. This suggests that HCV is an uncommon contributory factor for the development of non-Hodgkins lymphoma in the United Kingdom.

Entities:  

Mesh:

Year:  1996        PMID: 8907279     DOI: 10.3109/10428199609067589

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  13 in total

Review 1.  Hepatitis C virus infection and lymphoproliferative disorders.

Authors:  L R Peña; S Nand; N De Maria; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus.

Authors:  Ke Li; Lin Wang; Jun Cheng; Yin-Ying Lu; Ling-Xin Zhang; Jin-Song Mu; Yuan Hong; Yan Liu; Hui-Juan Duan; Gang Wang; Li Li; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Intestinal B cell lymphoma associated with chronic hepatitis C and celiac disease.

Authors:  Sahin Coban; Murat Palabiyikoğlu; Arzu Ensari; Ramazan Idilman; Seyfettin Köklü; Omer Faruk Yolcu; Necati Ormeci
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 4.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 5.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

6.  Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India.

Authors:  Subhash Varma; Madhav C Menon; Ashish Garg; Pankaj Malhotra; Arpita Sharma; Yogesh K Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-01-30       Impact factor: 6.047

7.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Hepatitis C virus-associated extrahepatic manifestations: a review.

Authors:  Damien Sène; Nicolas Limal; Patrice Cacoub
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 9.  Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors:  Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

10.  Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma.

Authors:  Z Salem; N Nuwaiyri-Salti; F Ramlawi; S Ramia
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.